Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...

A total of 80 top executives from global multinational companies are set to gather in Beijing to discuss a range of economic ...

US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump ...

A video of the company’s CEO has been altered to make it sound like he announced plans to reduce the world’s population by 50%.

Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.

Uncle Sam’s abiding ambivalence about having close ties with corporate America is getting some fresh, albeit unwelcome, ...

The finance sector is strongly represented in this year's attendees. HSBC Group Chief Executive Georges Elhedery is on the ...

The China Development Forum, scheduled for March 23-24, is expected to host key figures such as Blackstone Inc.’s Steve ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Global CEOs including Qualcomm Inc.’s Cristiano Amon and Saudi Aramco’s Amin Nasser will travel to Beijing for an annual ...